Showing results (131-140 of 194) with videos related to
Sort By:
Pageof 20
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 27, 2010
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal womenSteven R Cummings, Michael McClung, Jean-Yves Reginster, et al.Scientific Reports|March 23, 2021
Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritisAnne-Christine Bay-Jensen, Asger Bihlet, Inger Byrjalsen, et al.European Journal of Pharmacology|May 27, 2014
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic ratsMichael Feigh, Sara T Hjuler, Kim V Andreassen, et al.Diabetes/Metabolism Research and Reviews|February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapyKim Henriksen, Inger Byrjalsen, Per Qvist, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2010
Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesisSanne S Veidal, Efstathios Vassiliadis, Natasha Barascuk, et al.The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort StudyMichael R McClung, Richard D Wasnich, David J Hosking, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2004
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnoverLászló B Tankó, Yu Z Bagger, Peter Alexandersen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisCharles H Chesnut, Arne Skag, Claus Christiansen, et al.Current Medical Research and Opinion|December 14, 2011
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trialCyrus Cooper, Jean-Yves Reginster, Roland Chapurlat, et al.Assay and Drug Development Technologies|October 11, 2012
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failureMorten A Karsdal, Mette J Nielsen, Jannie M Sand, et al.Pageof 20